MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

166.10B

Vuru Grade

54.36/100

Current Price

$60.25
-0.885 (-1.448%)

Growth Price

$54.63
Overvalued by 9.32%

Stability Price

$20.59
Overvalued by 65.82%

Company Metrics

  • P/E 30.769
  • P/S 4.223
  • P/B 3.859
  • EPS 1.958
  • Cash ROIC 12.97%
  • Cash Ratio 0.70
  • Dividend 1.880 / 3.080 %
  • Avg. Vol. 10.64M
  • Shares 2.76B
  • Market Cap. 166.10B

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Burning Stock on the move: Merck & Co., Inc. (NYSE:MRK)
FactsReporter - 4 hours ago
Merck & Co., Inc. on 10/25/2016 reported its EPS as $1.07 with the analysts projecting the EPS of the stock as $0.99.
Merck & Co., Inc. (NYSE:MRK) Stock Rises, Analysts: Hold Rating - Review Fortune
Analysts' Recommendations Trending Stocks: Merck & Co., Inc. (NYSE:MRK ... - Money News
Analysts Upside For This Dividend Diamond: Merck & Co., Inc. (NYSE:MRK)
CSZ News - 7 hours ago
If investors are looking for a stable dividend stock with upside, Merck & Co., Inc. (NYSE:MRK) could be one that fits the bill.
Investor's Alert: Marathon Petroleum Corporation (NYSE:MPC), Merck & Co., Inc ...
FactsReporter - Dec 2, 2016
The company announced its last quarter financial performance results on 11/18/2016. Marathon Petroleum Corporation (NYSE:MPC) belongs to Oils-Energy sector that surged 1.53% in value when last trading session closed at $47.74.
Stocks in Review: Pfizer Inc. (PFE), Marathon Oil Corporation (MRO), AT&T Inc. (T) - iStreetWire
Research Analysis of Merck & Co., Inc. (NYSE:MRK)
FactsReporter - Nov 30, 2016
Merck & Co., Inc. (NYSE:MRK) has the market capitalization of $171.47 Billion. The company rocked its 52-Week High of $65.46 on Nov 10, 2016 and touched its 52-Week Low of $47.97 on Feb 8, 2016.
Recent analysts Ratings: Merck & Co., Inc. (NYSE:MRK) - News Oracle
Exxonmobil Investment Management Inc. TX Has $44065000 Stake in Merck & Co. (MRK) - The Cerbat Gem
Stock Analyst Opinions On Watch List: Merck & Co., Inc. (NYSE:MRK), Best Buy ...
Review Fortune - Nov 30, 2016
Merck & Co., Inc. (NYSE:MRK) made a 0.63% move from the market's previous close, putting the price on the $62.19 per share as of 11/29/2016.
Merck & Co., Inc. (NYSE:MRK) Analyst Estimates
The Independent Republic - Nov 25, 2016
Merck & Co., Inc. (NYSE:MRK) stock is presently standing at about $61.64 and lots of equity research firms seem to have a target price set on the stock.
Best Healthcare Stocks: Merck & Co., Inc. (NYSE:MRK), Bristol-Myers Squibb ... - TRA
Stock-research Ratings: Merck & Co., Inc. (NYSE:MRK), Morgan Stanley (NYSE:MS) - TWN
Traders Alert: Fiat Chrysler Automobiles N.V. (NYSE:FCAU), Merck & Co., Inc ...
FactsReporter - Dec 1, 2016
The company announced its last quarter financial performance results on 10/25/2016. Fiat Chrysler Automobiles N.V. (NYSE:FCAU) belongs to Auto-Tires-Trucks sector that surged 1.46% in value when last trading session closed at $7.66.
Stocks Trend Analysis: Fiat Chrysler Automobiles N.V. (NYSE:FCAU), Merck & Co ... - TRA
FDA Grants Priority Review to Supplemental Biologics License Application (sBLA ...
Business Wire (press release) - Dec 1, 2016
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S.
Investors React Positively To FDA's Acceptance of Merck & Co., Inc. (NYSE:MRK ... - Stock Market Daily (blog)
Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $9. ...
Nasdaq - Nov 11, 2016
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.
Ownership Change: Blackrock Group LTD Cut Position in Merck & Co INC (MRK) by ... - Chester News
Active Stocks in Frontline Rating- Merck & Co., Inc. (NYSE:MRK), Varian ...
Seneca Globe - 5 hours ago
Merck & Co., Inc. (NYSE:MRK) [Trend Analysis] swings ardently in active trading session, it climbs of 0.61% to close at $61.13.